Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tenghuangjiangu tablets registry study in knee osteoarthritis
ChiCTR1900026262Phase 4Not yet recruiting
- Sponsor
- Peking Union Medical College Hospital
- Start
- Apr 2019
- Countries
- 1
01
Overview
Phase 4, open-label trial of Tenghuangjiangu tablets in knee osteoarthritis (OA) (2 arms), sponsored by Peking Union Medical College Hospital. Primary endpoints: Rate of change in WOMAC score, Decrease in WOMAC score from baseline and 1 more. Planned start Apr 2019; status: not yet recruiting.
02
Drugs
Tenghuangjiangu tablets
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on ChiCTR1900026262.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900026262.